Taisaku Tanaka Selected Research

6- (5- chloro- 2- methoxybenzyl)- 4- alarkylaminocarbonyl- 1,4- diazepane- 2,5- dione

10/2011	Pharmacokinetic/pharmacodynamic analyses of chymase inhibitor SUN13834 in NC/Nga mice and prediction of effective dosage for atopic dermatitis patients.
12/2008	Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taisaku Tanaka Research Topics

Disease

4	Dermatitis 10/2011 - 04/2007
2	Atopic Dermatitis (Atopic Eczema) 10/2011 - 12/2008
1	Abdominal Aortic Aneurysm 08/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2017
1	Heart Failure 01/2017
1	Neoplasms (Cancer) 01/2017
1	Pruritus (Itching) 12/2008
1	Inflammation (Inflammations) 12/2008
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2003
1	Fibrosis (Cirrhosis) 10/2003

Drug/Important Bio-Agent (IBA)

5	Chymases (Chymase)IBA 08/2019 - 10/2003
2	6- (5- chloro- 2- methoxybenzyl)- 4- alarkylaminocarbonyl- 1,4- diazepane- 2,5- dioneIBA 10/2011 - 12/2008
1	Angiotensin IIIBA 08/2019
1	ApolipoproteinsIBA 08/2019
1	Temozolomide (Temodar)FDA LinkGeneric 01/2017
1	Alkylating AgentsIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	Picryl Chloride (Trinitrochlorobenzene)IBA 10/2011
1	DinitrofluorobenzeneIBA 12/2008
1	indium-bleomycinIBA 10/2003
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 10/2003
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2003

Therapy/Procedure

3	Oral Administration 10/2011 - 04/2007
1	Therapeutics 01/2017